C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/48 (2006.01) C12N 9/10 (2006.01) C12Q 1/02 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2519449
Disclosed herein is a method of screening a candidate compound for a TGase 2 inhibitor or activator, based on the finding that polymerization of I--.kappa.B.alpha. is mediated by TGase 2 and that polymerized I- .kappa.B.alpha. does not inhibit NF--.kappa.B, thereby leading to NF-.kappa.B activation. In the method, the level of free or polymerized I-.kappa.B.alpha. or the level of NF-.kappa.B is measured to determine whether the candidate compound is a TGase 2 inhibitor or activator.
Divulgation d'une méthode de sélection préalable d'un composé candidat pour un inhibiteur ou un activateur de la TGase, basée sur la constatation que la polymérisation de I-kappa.B.alpha. est médiée par la TGase 2 et que I-kappa.B.alpha polymérisée n'inhibe pas NF-kappaB, conduisant de la sorte à l'activation de NF-kappaB. Dans cette méthode, la teneur en I-kappa.B.alpha libre ou polymérisée ou celle de NF-kappaB est mesurée pour déterminer si le composé candidat est un inhibiteur ou un activateur de la TGase 2.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
National Cancer Center Korea
LandOfFree
Method for screening transglutaminase 2 inhibitor or activator does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for screening transglutaminase 2 inhibitor or activator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for screening transglutaminase 2 inhibitor or activator will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1537927